Delivery Order SPE2DR25D1100-SPE2DR26FDA0P
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $39,865.46 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 10,000 units of chorionic gonad, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
- Amerisourcebergen Drug Corp (Cencora, Inc.), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,754.45 by the Defense Logistics Agency Medical Supply Chain on January 15, 2026. This competitively awarded, firm fixed-price contract with an ultimate completion date of January 16, 2026 represents a child delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $1,592.61 to AmerisourceBergen Drug Corp on February 3, 2026, with an ultimate completion date of February 4, 2026. This firm fixed-price delivery order was issued under a non-competitive set-aside and is part of the company's broader pharmaceutical supply relationship with the federal government. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a task...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,679.16 by the Defense Logistics Agency (DLA) Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 8, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor based in Conshohocken, Pennsylvania. The contract represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a $1,834.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 26, 2026, with an ultimate completion date of the same day. This non-set-aside contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. The delivery order will be performed at the contractor's...
- The Defense Logistics Agency awarded a $22,710.45 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 21, 2026, under a firm fixed-price contract with a completion date of January 21, 2026. This non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $55,512.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 28, 2026, with completion targeted for January 29, 2026. This non-set-aside contract represents a child delivery order under AmerisourceBergen's parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031. The delivery order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a $1,947.12 delivery order to AmerisourceBergen Drug Corp on January 22, 2026, with an ultimate completion date of January 23, 2026. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made on a competitive basis with no set-aside designation, and the place of...
- The Defense Logistics Agency (DLA) awarded a $126,350.88 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 14, 2026, with a completion date of January 15, 2026. This non-set-aside competitive award is a child contract issued under Amerisourcebergen Drug Corp's parent organization, Cencora, Inc., and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order executed against the company's broader...
- The Defense Logistics Agency awarded a $5,116.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, with completion expected by January 14, 2026. This non-set-aside contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The delivery order is to be performed at the awardee's corporate office location in...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDA0PDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,980.53 to AmerisourceBergen Drug Corp for the supply of 10,000 units of chorionic gonad on January 15, 2026. This firm fixed-price delivery order, with a completion date of January 16, 2026, carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle that extends through December 2031 and serves as the primary procurement mechanism for pharmaceutical products and medical supplies supporting military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor specializing in the supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive federal contracting history demonstrates consistent capability to meet DLA procurement requirements through open competition, with contract awards ranging from small-value transactions to substantial orders. This delivery order aligns with the company's established role in supplying specialized pharmaceutical products to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 1/14/26 |